文献速递产科母胎医学

胎儿生长受限的产前检测与死产风险:基于人群的病例对照研究

Antenatal detection of fetal growth restriction and risk of stillbirth: population-based case-control study.
PubMed 文献 · Ultrasound Obstet Gynecol · 2020-01-01

法国REPERE病例对照研究纳入2012至2014年三个地区约每年3万例分娩,比较小于胎龄儿死产与活产的FGR产前检出率。FGR检出与死产风险的粗OR为1.4(95%CI 0.9-2.3),调整后OR为0.6(95%CI 0.3-1.0);≥28周分娩调整后OR为0.5(95%CI 0.2-1.0)。作者认为产前检出FGR对死产有保护作用,但超过40%的小于胎龄儿死产发生在已检出FGR之后。

要点

  • 病例组FGR检出率44.3%(35/79),对照组36.2%(154/426)。
  • 调整后OR为0.6(95%CI 0.3-1.0),提示检出FGR与死产风险降低相关。
  • 超过40%的小于胎龄儿死产发生在已检出FGR之后。

核心结论

  • 产前检出FGR对死产具有保护作用,但超过40%的小于胎龄儿死产发生在已检出FGR之后,提示需改进检出后的管理。

研究设计与样本

  • REPERE为在法国三个地区开展的病例对照研究,这三个地区合计每年约30000例分娩。
  • 病例为2012至2014年经基于人群的死产登记识别、孕周≥24周、不伴严重先天畸形的单胎小于胎龄儿死产。
  • 对照为2014年4月7日至6月8日9周期间符合相同纳入标准的活产。
  • 由受训调查员从病历和超声报告中提取数据。
  • 小于胎龄儿定义为出生体重低于法国定制标准的第10百分位。

主要发现

  • 研究期间共有92182例孕周≥22周的分娩,其中死产669例,符合纳入标准的单胎小于胎龄儿死产79例。
  • 病例组FGR检出率为44.3%(35/79),对照组为36.2%(154/426)。
  • FGR检出与死产风险的粗OR为1.4(95%CI 0.9-2.3)。
  • 调整产次、FGR危险因素、血管疾病及出生体重百分位后,OR为0.6(95%CI 0.3-1.0)。
  • 孕周≥28周分娩中,病例组与对照组检出率分别为38.3%与36.0%,调整后OR为0.5(95%CI 0.2-1.0)。

关键数值与推荐

  • FGR定义为以下七项预设参数中至少一项:病历或超声报告提及可疑FGR、超声报告提及可疑生长迟缓、记录的腹围或估计胎儿体重低于第10百分位、因监测生长或脐动脉多普勒异常转诊行额外超声检查。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Antenatal surveillance of intrauterine growth aims to detect growth-restricted fetuses (FGR), which face increased risk of stillbirth. Improving their detection could be an effective strategy for prevention of stillbirth. The French REPERE study was conducted to estimate the association between antenatal detection of FGR and risk of stillbirth. METHODS: REPERE is a case-control study performed in three French districts with a combined total of approximately 30 000 births annually. Cases were singleton small-for-gestational-age (SGA) stillbirths ≥ 24 weeks' gestation and without severe congenital anomaly, between 2012 and 2014, identified using a population-based stillbirth registry; controls were live births fulfilling the same inclusion criteria over a 9-week period from 7 April to 8 June 2014. Data were extracted by trained investigators from medical records and ultrasound reports. SGA was defined as birth weight < 10th percentile of French customized standards. FGR was defined by the presence of at least one of seven predefined parameters (suspected FGR mentioned in medical records or in ultrasound report, suspected faltering growth mentioned in an ultrasound report, documented abdominal circumference or estimated fetal weight < 10th percentile, referral for additional ultrasound examination to monitor growth or abnormal umbilical artery Doppler). We used logistic regression to estimate crude and adjusted odds ratios (ORs) for the association between detection of FGR and risk of stillbirth. Included covariables were parity, maternal medical history, vascular complications during pregnancy and birth-weight percentile, which are known to be associated with risk of detection of FGR and of stillbirth. RESULTS: During the study period, there were 92 182 births ≥ 22 weeks' gestation, including 669 stillbirths, of which 79 were singleton SGA stillbirths ≥ 24 weeks and without severe congenital anomaly. Of these cases, 44.3% (35/79) had FGR detected, compared with a detection rate of 36.2% in controls (154/426). The crude OR expressing the association between detection of FGR and risk of stillbirth was 1.4 (95% CI, 0.9-2.3) and the OR adjusted for parity, presence of risk factors for FGR, presence of vascular disorder and birth-weight percentile was 0.6 (95% CI, 0.3-1.0). Among deliveries ≥ 28 weeks, detection rates were 38.3% vs 36.0% for cases and controls, with an adjusted OR of 0.5 (95% CI, 0.2-1.0). CONCLUSION: Antenatal detection of FGR was protective against stillbirth, but over 40% of stillbirths among SGA fetuses occurred despite detection of FGR, pointing to the need to improve management following detection. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Ego A, Monier I, Skaare K, et al. Antenatal detection of fetal growth restriction and risk of stillbirth: population-based case-control study. Ultrasound Obstet Gynecol. 2020. PMID: 31364201. doi:10.1002/uog.20414

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。